On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K
周一,强生同意支付5千万美元,以解决与Emergent Biosolutions终止制造协议有关的索赔,涉及强生的covid-19生物-疫苗 - 8K